Houlihan Lokey reports fiscal fourth-quarter results on May 8 with options traders leaning notably bullish — an unusual posture for a financial-advisory firm heading into a print where M&A visibility has been clouded by macro uncertainty.
The clearest positioning signal is in the options market. The put/call ratio has collapsed to 0.095, well below its 20-day average of 0.152 and sitting near the 52-week floor of 0.089. That is close to one standard deviation below the recent mean — indicating call-side demand is heavily dominant rather than investors seeking downside protection. Short interest offers little in the way of pressure either. At 2.4% of the free float, it has drifted roughly 1.6% lower over the week, and borrow conditions remain extremely relaxed. Availability in the lending market is far from stressed, and cost to borrow at 0.66% — though it has more than doubled in a week — is still negligible in absolute terms. Together, the positioning picture reads as complacent rather than defensive.
Analysts have trimmed targets but not their conviction. Both Morgan Stanley and Goldman Sachs cut price targets in early April — Morgan Stanley to $193 from $205, Goldman to $184 from $210 — yet both retained positive ratings. The consensus mean target of $174.50 implies about 18% upside from HLI's current price of $147.23, a gap that reflects the Street's belief that the stock has been sold down beyond what fundamentals justify. The bear case centres on deal-count volatility: advisory revenues are lumpy, and a slow M&A environment can punish earnings in a single quarter. Bulls counter that Houlihan's restructuring franchise provides a natural offset when corporate stress rises — a dynamic that becomes more relevant in a higher-rate, tariff-disrupted environment. The dividend score ranks in the 99th percentile, signalling strong income credentials that anchor some of the longer-term holder base.
The stock has lost 5.6% over the past week, a sharper move than most peers. PJT Partners fell just 0.8% over the same period and Stifel Financial slipped less than 0.5%, while Moelis and Piper Sandler each dropped more than 8%. HLI's slide sits roughly in the middle of that peer range — not a dramatic outlier, but notable given it has underperformed some of the most correlated names. One prior earnings reaction is on record: the January print saw HLI fall 6.8% on the day and extend to a 7% loss over the following five sessions, a reminder that the stock can move meaningfully on a miss or cautious outlook. Insider activity over the past 90 days has been net selling of around $1 million, led by the General Counsel — low-significance disposals that suggest routine rather than alarm.
The May 8 print will test whether Houlihan's restructuring revenues can offset any softness in traditional M&A advisory, and whether management guidance reassures a market that has already begun discounting a slower deal environment.
See the live data behind this article on ORTEX.
Open HLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
